Clinical Trial Update: Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated a four-drug combination (doxorubicin, pembrolizumab, vinblastine, dacarbazine) for classical Hodgkin lymphoma. The study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• DTIC-Dome (dacarbazine)
• KEYTRUDA (PEMBROLIZUMAB)
• Velban (vinblastine)

Snippet

Sponsor: University of Washington | Conditions: Classical Hodgkin Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-01-09